Maharashtra FDA Sees 557% Rise in Drug Complaints, Intensifies Crackdown

Under the leadership of Tukaram Mundhe, the Maharashtra Food and Drug Administration has intensified its enforcement against illegal pharmaceuticals. The agency noted a 557% increase in complaints related to drug safety and distribution over the last three months, a sharp rise that has prompted a more aggressive regulatory response. In response, the FDA has expanded its inspection teams, increased on‑site audits of pharmacies and manufacturing units, and tightened penalties for violations. Officials say the crackdown aims to protect consumers from substandard and counterfeit medicines and to restore confidence in the state’s drug supply chain.